Single-cell analysis of the nervous system at small and large scales with instant partitions
PW Frazel,K Fricano-Kugler,AA May-Zhang,O’Dea,P Prakash,NM Desmet,H Lee,RH Meltzer,KM Fontanez,P Hettige,Y Agam,G Lithwick-Yanai,D Lipson,BW Luikart,JD Dasen,Liddelow,Frazel,P.,Fricano-Kugler,C.,May-Zhang,A. A.,O'Dea,M. R.,Prakash,P.,Desmet,N.,Lee,H.,Meltzer,R. H.,Fontanez,K.,Hettige,P.,Lithwick-Yanai,G.,Lipson,D.,Luikart,B. W.,Dasen,J. S.,S.
DOI: https://doi.org/10.1101/2023.07.14.549051
2023-07-15
bioRxiv
Abstract:Single-cell RNA sequencing is a new frontier across all biology, particularly in neuroscience. While powerful for answering numerous neuroscience questions, limitations in sample input size, and initial capital outlay can exclude some researchers from its application. Here, we tested a recently introduced method for scRNAseq across diverse scales and neuroscience experiments. We benchmarked against a major current scRNAseq technology and found that PIPseq performed similarly, in line with earlier benchmarking data. Across dozens of samples, PIPseq recovered many brain cell types at small and large scales (1,000-100,000 cells/sample) and was able to detect differentially expressed genes in an inflammation paradigm. Similarly, PIPseq could detect expected and new differentially expressed genes in a brain single cell suspension from a knockout mouse model; it could also detect rare, virally-labelled cells following lentiviral targeting and gene knockdown. Finally, we used PIPseq to investigate gene expression in a nontraditional model species, the little skate (Leucoraja erinacea). In total, PIPSeq was able to detect single-cell gene expression changes across models and species, with an added benefit of large scale capture and sequencing of each sample.